{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T08:47:14Z","timestamp":1794818834859,"version":"4.9.1"},"reference-count":47,"publisher":"MDPI AG","issue":"23","license":[{"start":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T00:00:00Z","timestamp":1764374400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012190","name":"Ministry of Science and Higher Education of the Russian Federation","doi-asserted-by":"crossref","award":["075-15-2025-558"],"award-info":[{"award-number":["075-15-2025-558"]}],"id":[{"id":"10.13039\/501100012190","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Alzheimer\u2019s disease is characterized by the accumulation of neurotoxic forms of amyloid-beta (A\u03b2) in the brain, leading to synaptic dysfunction, neuroinflammation, and neuronal death. The tetrapeptide HAEE crosses the blood\u2013brain barrier (BBB), inhibits the formation of toxic A\u03b2 oligomers, and reduces amyloid burden in vivo. However, the mechanisms of HAEE\u2019s anti-amyloidogenic effect remained incompletely understood. In this study, we investigated the mechanism of HAEE-dependent A\u03b2 clearance both in vitro and in vivo. Using ELISA, we assessed the HAEE effect on the levels of A\u03b2, IL-6, and TNF\u03b1 in mouse brain tissue following intracerebroventricular administration. The mechanism of the anti-A\u03b2 effect of HAEE was studied using primary brain cell cultures and a BBB transwell model through ELISA, flow cytometry, and microscopy. We showed that HAEE reduced A\u03b2 level by 35% and IL-6 level by 40% in mouse brain tissue. HAEE enhanced A\u03b2 clearance via LRP1- and PgP-dependent A\u03b2 transport through the BBB and doubled the rate of A\u03b2 degradation by microglia. In addition to inhibition of A\u03b2 aggregation, HAEE dissolved already formed A\u03b2 oligomers. The HAEE-induced decrease in IL-6 levels in the mouse brain was associated with reduced pro-inflammatory activation of microglia. Thus, HAEE\u2019s effect against A\u03b2-related neuropathologies is realized through a decrease in the level of toxic A\u03b2 oligomer and inhibition of neuroinflammation.<\/jats:p>","DOI":"10.3390\/ijms262311591","type":"journal-article","created":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T08:13:49Z","timestamp":1764576829000},"page":"11591","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The Tetrapeptide HAEE Promotes Amyloid-Beta Clearance from the Brain"],"prefix":"10.3390","volume":"26","author":[{"given":"Kristina A.","family":"Mukhina","sequence":"first","affiliation":[{"name":"Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Vavilov Str., 32, 119991 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kseniya B.","family":"Varshavskaya","sequence":"additional","affiliation":[{"name":"Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Vavilov Str., 32, 119991 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra D.","family":"Rybak","sequence":"additional","affiliation":[{"name":"Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Vavilov Str., 32, 119991 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktor V.","family":"Grishchenko","sequence":"additional","affiliation":[{"name":"Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Vavilov Str., 32, 119991 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena V.","family":"Kuzubova","sequence":"additional","affiliation":[{"name":"Research Institute of Pharmacology of Living Systems, Belgorod State National Research University, 85 Pobedy St., 308015 Belgorod, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5402-0697","authenticated-orcid":false,"given":"Mikhail V.","family":"Korokin","sequence":"additional","affiliation":[{"name":"Research Institute of Pharmacology of Living Systems, Belgorod State National Research University, 85 Pobedy St., 308015 Belgorod, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga I.","family":"Kechko","sequence":"additional","affiliation":[{"name":"Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Vavilov Str., 32, 119991 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir A.","family":"Mitkevich","sequence":"additional","affiliation":[{"name":"Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Vavilov Str., 32, 119991 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,11,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"937486","DOI":"10.3389\/fnagi.2022.937486","article-title":"Global, regional, and national burden of Alzheimer\u2019s disease and other dementias","volume":"14","author":"Li","year":"2022","journal-title":"Front. Aging Neurosci."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/procel\/pwae026","article-title":"Alzheimer\u2019s disease: Insights into pathology, molecular mechanisms, and therapy","volume":"16","author":"Zheng","year":"2025","journal-title":"Protein Cell"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e202215785","DOI":"10.1002\/anie.202215785","article-title":"Imaging Amyloid-\u03b2 Membrane Interactions: Ion-Channel Pores and Lipid-Bilayer Permeability in Alzheimer\u2019s Disease","volume":"62","author":"Viles","year":"2023","journal-title":"Angew. Chem. (Int. Ed. Engl.)"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1021\/cn2001238","article-title":"Isolated amyloid-\u03b2(1-42) protofibrils, but not isolated fibrils, are robust stimulators of microglia","volume":"3","author":"Paranjape","year":"2012","journal-title":"ACS Chem. Neurosci."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Kolobova, E., Petrushanko, I., Mitkevich, V., Makarov, A.A., and Grigorova, I.L. (2024). \u03b2-Amyloids and Immune Responses Associated with Alzheimer\u2019s Disease. Cells, 13.","DOI":"10.3390\/cells13191624"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.neuroscience.2025.10.011","article-title":"Anti-amyloid monoclonal antibody therapies in Alzheimer\u2019s disease\u2014A scoping review","volume":"589","author":"Elamin","year":"2025","journal-title":"Neuroscience"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Francis, E., Paylor, S., Van, C., Mathews, B., Sobhanian, M.J., Mansour, D.Z., Hennawi, G., and Brandt, N.J. (2025). Review of anti-amyloid-beta (A\u03b2) monoclonal antibodies for the treatment of Alzheimer\u2019s disease. Expert Rev. Clin. Pharmacol., 1\u201316.","DOI":"10.1080\/17512433.2025.2556122"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1134\/S0006297918090079","article-title":"Anti-amyloid Therapy of Alzheimer\u2019s Disease: Current State and Prospects. Biochemistry","volume":"83","author":"Kozin","year":"2018","journal-title":"Biokhimiia"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"100657","DOI":"10.1016\/j.lanepe.2023.100657","article-title":"The affordability of lecanemab, an amyloid-targeting therapy for Alzheimer\u2019s disease: An EADC-EC viewpoint","volume":"29","author":"Wimo","year":"2023","journal-title":"Lancet Reg. Health Eur."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Kechko, O.I., Mukhina, K.A., Yanvarev, D.V., Eremina, S.Y., Katkova-Zhukotskaya, O.A., Chaprov, K.D., Drutskaya, M.S., Kozin, S.A., Makarov, A.A., and Mitkevich, V.A. (2025). Therapeutic Potential of HAEEPGP Peptide Against \u03b2-Amyloid Induced Neuropathology. Mol. Neurobiol., 63.","DOI":"10.1007\/s12035-025-05349-8"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Barykin, E.P., Garifulina, A.I., Tolstova, A.P., Anashkina, A.A., Adzhubei, A.A., Mezentsev, Y.V., Shelukhina, I.V., Kozin, S.A., Tsetlin, V.I., and Makarov, A.A. (2020). Tetrapeptide Ac-HAEE-NH2 Protects \u03b14\u03b22 nAChR from Inhibition by A\u03b2. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21176272"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"L84","DOI":"10.1016\/j.bpj.2010.09.015","article-title":"Minimal Zn2+ binding site of amyloid-\u03b2","volume":"99","author":"Tsvetkov","year":"2010","journal-title":"Biophys. J."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Zolotarev, Y.A., Mitkevich, V.A., Shram, S.I., Adzhubei, A.A., Tolstova, A.P., Talibov, O.B., Dadayan, A.K., Myasoyedov, N.F., Makarov, A.A., and Kozin, S.A. (2021). Pharmacokinetics and Molecular Modeling Indicate nAChR\u03b14-Derived Peptide HAEE Goes through the Blood-Brain Barrier. Biomolecules, 11.","DOI":"10.3390\/biom11060909"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1152\/physrev.00050.2017","article-title":"Blood-Brain Barrier: From Physiology to Disease and Back","volume":"99","author":"Sweeney","year":"2019","journal-title":"Physiol. Rev."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s00702-010-0433-4","article-title":"The role of microglia in amyloid clearance from the AD brain","volume":"117","author":"Lee","year":"2010","journal-title":"J. Neural Transm."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s13024-016-0098-z","article-title":"Accumulation of amyloid-\u03b2 by astrocytes result in enlarged endosomes and microvesicle-induced apoptosis of neurons","volume":"11","author":"Nikitidou","year":"2016","journal-title":"Mol. Neurodegener."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1038\/s41591-025-03574-1","article-title":"Microglial mechanisms drive amyloid-\u03b2 clearance in immunized patients with Alzheimer\u2019s disease","volume":"31","author":"Simonton","year":"2025","journal-title":"Nat. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"4252","DOI":"10.1523\/JNEUROSCI.5572-08.2009","article-title":"Microglia mediate the clearance of soluble Abeta through fluid phase macropinocytosis","volume":"29","author":"Mandrekar","year":"2009","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"849","DOI":"10.3233\/JAD-150031","article-title":"Peripherally Applied Synthetic Tetrapeptides HAEE and RADD Slow Down the Development of Cerebral \u03b2-Amyloidosis in A\u03b2PP\/PS1 Transgenic Mice","volume":"46","author":"Tsvetkov","year":"2015","journal-title":"J. Alzheimers Dis."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Wang, C., Zong, S., Cui, X., Wang, X., Wu, S., Wang, L., Liu, Y., and Lu, Z. (2023). The effects of microglia-associated neuroinflammation on Alzheimer\u2019s disease. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1117172"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Simpson, D.S.A., and Oliver, P.L. (2020). ROS Generation in Microglia: Understanding Oxidative Stress and Inflammation in Neurodegenerative Disease. Antioxidants, 9.","DOI":"10.3390\/antiox9080743"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Alkhalifa, A.E., Al Mokhlf, A., Ali, H., Al-Ghraiybah, N.F., and Syropoulou, V. (2025). Anti-Amyloid Monoclonal Antibodies for Alzheimer\u2019s Disease: Evidence, ARIA Risk, and Precision Patient Selection. J. Pers. Med., 15.","DOI":"10.3390\/jpm15090437"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s00702-017-1820-x","article-title":"Amyloid \u03b2 oligomers (A\u03b2Os) in Alzheimer\u2019s disease","volume":"125","author":"Mroczko","year":"2018","journal-title":"J. Neural Transm."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrm2101","article-title":"Soluble protein oligomers in neurodegeneration: Lessons from the Alzheimer\u2019s amyloid \u03b2-peptide","volume":"8","author":"Haass","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1016\/j.bbamem.2018.04.004","article-title":"Interactions between amyloid \u03b2 peptide and lipid membranes","volume":"1860","author":"Niu","year":"2018","journal-title":"Biochim. Biophys. Acta Biomembranes"},{"key":"ref_26","first-page":"31","article-title":"A\u03b2 Plaques","volume":"1","author":"Walker","year":"2020","journal-title":"Free Neuropathol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s10787-019-00580-x","article-title":"Activation of microglia and astrocytes: A roadway to neuroinflammation and Alzheimer\u2019s disease","volume":"27","author":"Kaur","year":"2019","journal-title":"Inflammopharmacology"},{"key":"ref_28","first-page":"309","article-title":"Zn-dependent \u03b2-amyloid Aggregation and its Reversal by the Tetrapeptide HAEE","volume":"14","author":"Mitkevich","year":"2023","journal-title":"Aging Dis."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"31520","DOI":"10.1021\/acsomega.1c03915","article-title":"Proteolysis of Amyloid \u03b2 by Lysosomal Enzymes as a Function of Fibril Morphology","volume":"6","author":"Lambeth","year":"2021","journal-title":"ACS Omega"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"216","DOI":"10.5607\/en23014","article-title":"Advances in Amyloid-\u03b2 Clearance in the Brain and Periphery: Implications for Neurodegenerative Diseases","volume":"32","author":"Ullah","year":"2023","journal-title":"Exp. Neurobiol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/s41392-025-02426-1","article-title":"Rapid amyloid-\u03b2 clearance and cognitive recovery through multivalent modulation of blood-brain barrier transport","volume":"10","author":"Chen","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.1172\/JCI25247","article-title":"P-glycoprotein deficiency at the blood-brain barrier increases amyloid-beta deposition in an Alzheimer disease mouse model","volume":"115","author":"Cirrito","year":"2005","journal-title":"J. Clin. Investig."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/febs.15148","article-title":"P-glycoprotein: A role in the export of amyloid-\u03b2 in Alzheimer\u2019s disease?","volume":"287","author":"Chai","year":"2020","journal-title":"FEBS J."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12987-021-00245-4","article-title":"Protecting P-glycoprotein at the blood-brain barrier from degradation in an Alzheimer\u2019s disease mouse model","volume":"18","author":"Ding","year":"2021","journal-title":"Fluids Barriers CNS"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/s12974-022-02565-0","article-title":"Astrocytic and microglial cells as the modulators of neuroinflammation in Alzheimer\u2019s disease","volume":"19","author":"Singh","year":"2022","journal-title":"J. Neuroinflamm."},{"key":"ref_36","first-page":"5","article-title":"Anti-Amyloid Monoclonal Antibodies for the Treatment of Alzheimer\u2019s Disease","volume":"38","author":"Cummings","year":"2024","journal-title":"BioDrugs Clin. Immunother. Biopharm. Gene Ther."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"e084622","DOI":"10.1002\/alz.084622","article-title":"Characterization of the first TREM2 small molecule agonist, VG-3927, for clinical development in Alzheimer\u2019s disease","volume":"20","author":"Mirescu","year":"2025","journal-title":"Alzheimers Dement."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1186\/s12974-024-03277-3","article-title":"Interleukin-6 deficiency reduces neuroinflammation by inhibiting the STAT3-cGAS-STING pathway in Alzheimer\u2019s disease mice","volume":"21","author":"Liu","year":"2024","journal-title":"J. Neuroinflamm."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/s41398-021-01349-z","article-title":"Pro-inflammatory interleukin-6 signaling links cognitive impairments and peripheral metabolic alterations in Alzheimer\u2019s disease","volume":"11","author":"Lyra","year":"2021","journal-title":"Transl. Psychiatry"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"100013","DOI":"10.1016\/j.tjpad.2024.100013","article-title":"Microglial activation states and their implications for Alzheimer\u2019s Disease","volume":"12","author":"Valiukas","year":"2025","journal-title":"J. Prev. Alzheimers Dis."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/s41420-025-02600-y","article-title":"The multifaceted roles of apolipoprotein E4 in Alzheimer\u2019s disease pathology and potential therapeutic strategies","volume":"11","author":"Chen","year":"2025","journal-title":"Cell Death Discov."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"7551","DOI":"10.1038\/s41467-025-62995-1","article-title":"Astrocyte priming enhances microglial A\u03b2 clearance and is compromised by APOE4","volume":"16","author":"Lee","year":"2025","journal-title":"Nat. Commun."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Mukhina, K.A., Kechko, O.I., Osypov, A.A., Petrushanko, I.Y., Makarov, A.A., Mitkevich, V.A., and Popova, I.Y. (2025). Short-Term Inhibition of NOX2 Prevents the Development of A\u03b2-Induced Pathology in Mice. Antioxidants, 14.","DOI":"10.3390\/antiox14060663"},{"key":"ref_44","unstructured":"Paxinos, G., and Franklin, K.B.J. (2001). The Mouse Brain in Stereotaxic Coordinates, Academic Press."},{"key":"ref_45","first-page":"50079","article-title":"Isolation and culture of mouse cortical astrocytes","volume":"71","author":"Schildge","year":"2013","journal-title":"J. Vis. Exp."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Varshavskaya, K.B., Petrushanko, I.Y., Mitkevich, V.A., Barykin, E.P., and Makarov, A.A. (2024). Post-translational modifications of beta-amyloid alter its transport in the blood-brain barrier in vitro model. Front. Mol. Neurosci., 17.","DOI":"10.3389\/fnmol.2024.1362581"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jalz.2012.11.005","article-title":"New ELISAs with high specificity for soluble oligomers of amyloid \u03b2-protein detect natural A\u03b2 oligomers in human brain but not CSF","volume":"9","author":"Yang","year":"2013","journal-title":"Alzheimers Dement. J. Alzheimers Assoc."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/23\/11591\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T05:12:44Z","timestamp":1764652364000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/23\/11591"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,29]]},"references-count":47,"journal-issue":{"issue":"23","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["ijms262311591"],"URL":"https:\/\/doi.org\/10.3390\/ijms262311591","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,29]]}}}